The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies

A major difference in the revised diagnostic criteria for Alzheimer’s disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow the identification of preclinical AD due to AD neuropathological processes. However, AD-specific fluid biomarkers which specifically disting...

Descripción completa

Detalles Bibliográficos
Autores principales: Wennström, Malin, Surova, Yulia, Hall, Sara, Nilsson, Christer, Minthon, Lennart, Hansson, Oskar, Nielsen, Henrietta M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536228/
https://www.ncbi.nlm.nih.gov/pubmed/26270969
http://dx.doi.org/10.1371/journal.pone.0135458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536228/
https://www.ncbi.nlm.nih.gov/pubmed/26270969
http://dx.doi.org/10.1371/journal.pone.0135458

Ejemplares similares